Search
Pinacidil
go.drugbank.com/drugs/DB06762ApprovedThe above processes result in reduced blood pressure. This drug has been discontinued by the FDA. … Pinacidil is a cyanoguanidine drug that acts by opening ATP-sensitive potassium channels, leading to peripheral vasodilatation of arterioles and decreasing peripheral vascular resistance.
Categories: Arteriolar Smooth Muscle, Agents Acting OnTrimethyltetradecylammonium
go.drugbank.com/drugs/DB17342ExperimentalSynonyms: Tetradonium ion, 1-tetradecanaminium, n,n,n-trimethyl-Categories: Compounds used in a research, industrial, or household setting3,4-Dihydroxycinnamic Acid
go.drugbank.com/drugs/DB01880InvestigationalCategories: Compounds used in a research, industrial, or household settingAminoethyl nitrate
go.drugbank.com/drugs/DB13585ExperimentalCategories: Vasodilators Used in Cardiac DiseasesZirconium dioxide
go.drugbank.com/drugs/DB16552InvestigationalCategories: Compounds used in a research, industrial, or household settingOxyfedrine
go.drugbank.com/drugs/DB13398ExperimentalCategories: Vasodilators Used in Cardiac Diseases, Compounds used in a research, industrial, or household settingGuanidine
go.drugbank.com/drugs/DB00536ApprovedIt is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. … (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC.
Taberminogene vadenovec
go.drugbank.com/drugs/DB05011ExperimentalThe initial target market is haemodialysis graft access surgery, a procedure in which patients whose kidneys have failed have a plastic tube grafted between blood vessels generally in their forearm so … EG004 has completed a Phase II trial, this being the first part of the Phase II/III study for which it has received approval from the US Recombinant DNA Advisory Committee (RAC).
Ciluprevir
go.drugbank.com/drugs/DB05868InvestigationalThe compound, named BILN 2061, is an orally active inhibitor of the HCV NS3 protease and the first member of this new drug class to be tested in humans.